ZW14480A1 - Pharmaceutical ethers preparation use and intermediates therefore and their preparation - Google Patents
Pharmaceutical ethers preparation use and intermediates therefore and their preparationInfo
- Publication number
- ZW14480A1 ZW14480A1 ZW144/80A ZW14480A ZW14480A1 ZW 14480 A1 ZW14480 A1 ZW 14480A1 ZW 144/80 A ZW144/80 A ZW 144/80A ZW 14480 A ZW14480 A ZW 14480A ZW 14480 A1 ZW14480 A1 ZW 14480A1
- Authority
- ZW
- Zimbabwe
- Prior art keywords
- preparation
- intermediates
- pharmaceutical
- ethers
- preparation use
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/125—Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/30—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing —CHO groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/74—Unsaturated compounds containing —CHO groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7922781 | 1979-06-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZW14480A1 true ZW14480A1 (en) | 1982-03-17 |
Family
ID=10506199
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZW144/80A ZW14480A1 (en) | 1979-06-29 | 1980-06-27 | Pharmaceutical ethers preparation use and intermediates therefore and their preparation |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4410537A (fi) |
| EP (1) | EP0022229B1 (fi) |
| JP (1) | JPS5649335A (fi) |
| KR (2) | KR850000073B1 (fi) |
| AU (1) | AU545274B2 (fi) |
| DE (1) | DE3061269D1 (fi) |
| DK (1) | DK159770C (fi) |
| FI (1) | FI71929C (fi) |
| GB (1) | GB2053218B (fi) |
| GR (1) | GR68748B (fi) |
| HU (1) | HU190774B (fi) |
| IL (1) | IL60422A (fi) |
| IT (1) | IT1133025B (fi) |
| MW (1) | MW2380A1 (fi) |
| OA (1) | OA06699A (fi) |
| ZA (1) | ZA803880B (fi) |
| ZM (1) | ZM5780A1 (fi) |
| ZW (1) | ZW14480A1 (fi) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0054924B1 (en) * | 1980-12-18 | 1986-08-06 | The Wellcome Foundation Limited | Pharmaceutical compounds, their preparation and use |
| GB8606913D0 (en) * | 1986-03-20 | 1986-04-23 | Hider R C | Treatment of sickle cell disease |
| AU6021598A (en) | 1997-01-09 | 1998-08-03 | Cohesion Technologies, Inc. | Methods and apparatuses for making swellable uniformly shaped devices from polymeric materials |
| US7129274B1 (en) | 1999-11-05 | 2006-10-31 | Emisphere Technologies Inc. | Phenoxy carboxylic acid compounds and compositions for delivering active agents |
| CA2388240C (en) * | 1999-11-05 | 2010-04-20 | Emisphere Technologies, Inc. | Phenoxy carboxylic acid compounds and compositions for delivering active agents |
| US7279597B1 (en) | 1999-11-05 | 2007-10-09 | Emisphere Technologies, Inc. | Phenyl amine carboxylic acid compounds and compositions for delivering active agents |
| AU2001245823A1 (en) | 2000-03-17 | 2001-10-03 | Corixa Corporation | Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors |
| US8246969B2 (en) | 2001-11-16 | 2012-08-21 | Skinmedica, Inc. | Compositions containing aromatic aldehydes and their use in treatments |
| AU2012204164A1 (en) | 2011-01-07 | 2013-07-25 | Allergan, Inc. | Melanin modification compositions and methods of use |
| WO2013102145A1 (en) | 2011-12-28 | 2013-07-04 | Global Blood Therapeutics, Inc. | Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation |
| HUE035069T2 (en) | 2011-12-28 | 2018-05-02 | Global Blood Therapeutics Inc | Substituted benzaldehyde compounds and their use to increase tissue oxygenation |
| US9604999B2 (en) | 2013-03-15 | 2017-03-28 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US10100043B2 (en) | 2013-03-15 | 2018-10-16 | Global Blood Therapeutics, Inc. | Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation |
| PE20161035A1 (es) | 2013-03-15 | 2016-11-13 | Global Blood Therapeutics Inc | Compuestos y usos de estos para la modulacion de la hemoglobina |
| US20140274961A1 (en) | 2013-03-15 | 2014-09-18 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US9422279B2 (en) | 2013-03-15 | 2016-08-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US9458139B2 (en) | 2013-03-15 | 2016-10-04 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US9802900B2 (en) | 2013-03-15 | 2017-10-31 | Global Blood Therapeutics, Inc. | Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin |
| CA2903022C (en) | 2013-03-15 | 2021-11-09 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US8952171B2 (en) | 2013-03-15 | 2015-02-10 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| KR20150132146A (ko) | 2013-03-15 | 2015-11-25 | 글로벌 블러드 테라퓨틱스, 인크. | 헤모글로빈 조정을 위한 화합물 및 이의 용도 |
| US10266551B2 (en) | 2013-03-15 | 2019-04-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| EP3816155A1 (en) * | 2013-08-23 | 2021-05-05 | Virginia Commonwealth University | Ester nitrates derivatives of aromatic aldehydes with multiple pharmalogic properties to treat sickle cell disease |
| EA201992707A1 (ru) | 2013-11-18 | 2020-06-30 | Глобал Блад Терапьютикс, Инк. | Соединения и их применения для модуляции гемоглобина |
| JP6809681B2 (ja) | 2014-02-07 | 2021-01-06 | グローバル ブラッド セラピューティクス インコーポレイテッド | ２−ヒドロキシ−６−（（２−（１−イソプロピル−１ｈ−ピラゾール−５−イル）ピリジン−３−イル）メトキシ）ベンズアルデヒドの遊離塩基の結晶多形 |
| US10238650B2 (en) | 2015-03-06 | 2019-03-26 | Beyondspring Pharmaceuticals, Inc. | Method of treating cancer associated with a RAS mutation |
| MA41841A (fr) | 2015-03-30 | 2018-02-06 | Global Blood Therapeutics Inc | Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs |
| TW201731509A (zh) | 2015-12-04 | 2017-09-16 | 全球血液治療公司 | 針對２-羥基-６-（（２-（１-異丙基-１ｈ-吡唑-５-基）吡啶-３-基）甲氧基）-苯甲醛之劑量方案 |
| SG11201806583XA (en) * | 2016-02-08 | 2018-09-27 | Beyondspring Pharmaceuticals Inc | Compositions containing tucaresol or its analogs |
| TWI663160B (zh) | 2016-05-12 | 2019-06-21 | 全球血液治療公司 | 用於合成2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)-吡啶-3-基)甲氧基)苯甲醛之方法 |
| TW202332423A (zh) | 2016-10-12 | 2023-08-16 | 美商全球血液治療公司 | 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑 |
| WO2019182938A1 (en) * | 2018-03-22 | 2019-09-26 | Virginia Commonwealth University | Aromatic aldehydes with sustained and enhanced in vitro and in vivo pharmacologic activity to treat sickle cell disease |
| EP3860975B1 (en) | 2018-10-01 | 2023-10-18 | Global Blood Therapeutics, Inc. | Modulators of hemoglobin for the treatment of sickle cell disease |
| EP4046988A1 (en) | 2018-11-19 | 2022-08-24 | Global Blood Therapeutics, Inc. | 2-formyl-3-hydroxyphenyloxymethyl compounds capable of modulating hemoglobin |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LU36787A1 (fi) * | 1958-04-30 | |||
| CH543472A (fr) * | 1969-01-31 | 1973-10-31 | Orchimed Sa | Procédé pour la préparation d'acides phénoxyalcoyl-carboxyliques |
| DE2209128C3 (de) | 1971-03-05 | 1981-10-22 | CIBA-GEIGY AG, 4002 Basel | Bis-Stilbenverbindungen, Verfahren zu deren Herstellung und deren Verwendung als optische Aufheller |
| CH550776A (de) | 1971-03-05 | 1974-06-28 | Ciba Geigy Ag | Herstellung neuer bis-stilbenverbindungen. |
| GB1511645A (en) | 1974-05-31 | 1978-05-24 | Univ Ife | Sickle cell anaemia treatment |
| US4137309A (en) * | 1976-10-14 | 1979-01-30 | The Procter & Gamble Company | Therapeutic treatment |
-
1980
- 1980-06-27 HU HU801601A patent/HU190774B/hu not_active IP Right Cessation
- 1980-06-27 ZA ZA00803880A patent/ZA803880B/xx unknown
- 1980-06-27 KR KR1019800002541A patent/KR850000073B1/ko active
- 1980-06-27 IT IT49108/80A patent/IT1133025B/it active
- 1980-06-27 MW MW23/80A patent/MW2380A1/xx unknown
- 1980-06-27 IL IL60422A patent/IL60422A/xx not_active IP Right Cessation
- 1980-06-27 DE DE8080103657T patent/DE3061269D1/de not_active Expired
- 1980-06-27 AU AU59697/80A patent/AU545274B2/en not_active Ceased
- 1980-06-27 JP JP8764580A patent/JPS5649335A/ja active Granted
- 1980-06-27 FI FI802052A patent/FI71929C/fi not_active IP Right Cessation
- 1980-06-27 ZW ZW144/80A patent/ZW14480A1/xx unknown
- 1980-06-27 GR GR62311A patent/GR68748B/el unknown
- 1980-06-27 ZM ZM57/80A patent/ZM5780A1/xx unknown
- 1980-06-27 EP EP80103657A patent/EP0022229B1/en not_active Expired
- 1980-06-27 GB GB8021219A patent/GB2053218B/en not_active Expired
- 1980-06-27 DK DK279780A patent/DK159770C/da not_active IP Right Cessation
- 1980-08-09 OA OA57193A patent/OA06699A/xx unknown
-
1981
- 1981-06-09 US US06/271,950 patent/US4410537A/en not_active Expired - Lifetime
-
1984
- 1984-03-13 KR KR1019840001263A patent/KR850000072B1/ko not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IL60422A0 (en) | 1980-09-16 |
| KR840004668A (ko) | 1984-10-22 |
| DK279780A (da) | 1980-12-30 |
| DK159770B (da) | 1990-12-03 |
| JPS5649335A (en) | 1981-05-02 |
| GB2053218B (en) | 1984-01-25 |
| EP0022229A1 (en) | 1981-01-14 |
| KR830002693A (ko) | 1983-05-30 |
| IT8049108A0 (it) | 1980-06-27 |
| KR850000072B1 (ko) | 1985-02-18 |
| OA06699A (fr) | 1982-05-31 |
| AU545274B2 (en) | 1985-07-11 |
| US4410537A (en) | 1983-10-18 |
| IL60422A (en) | 1984-06-29 |
| AU5969780A (en) | 1981-01-08 |
| FI71929C (fi) | 1987-03-09 |
| IT1133025B (it) | 1986-07-09 |
| FI802052A (fi) | 1980-12-30 |
| FI71929B (fi) | 1986-11-28 |
| KR850000073B1 (ko) | 1985-02-18 |
| ZA803880B (en) | 1982-02-24 |
| HU190774B (en) | 1986-11-28 |
| GR68748B (fi) | 1982-02-16 |
| EP0022229B1 (en) | 1982-12-08 |
| DE3061269D1 (en) | 1983-01-13 |
| DK159770C (da) | 1991-04-22 |
| MW2380A1 (en) | 1982-03-10 |
| JPH0154339B2 (fi) | 1989-11-17 |
| GB2053218A (en) | 1981-02-04 |
| ZM5780A1 (en) | 1983-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZW14480A1 (en) | Pharmaceutical ethers preparation use and intermediates therefore and their preparation | |
| GB2055800B (en) | Guanidinothiazoles and their preparation and use | |
| ZA818741B (en) | Pharmaceutical compounds,preparation,use and intermediates therefor and their preparation | |
| ZA803567B (en) | Pharmaceutical preparations | |
| GB2046737B (en) | Antihypercholesteraemic agent monacolin k and its preparation | |
| NZ189438A (en) | Perhaloalkylvinylcyclopropanecarboxylates intermediates and pharmaceutical compositions | |
| GB2065122B (en) | Basic ethers their preparation and pharmaceutical compositions containing the same | |
| DE3064823D1 (en) | Pyridyl-2-oxy-phenyloxime ethers and esters, their preparation and their use as herbicides | |
| IL60874A (en) | Preparation of 4-fluoro-3-phenoxy-benzaldehyde,intermediates therefor and their preparation | |
| NZ191709A (en) | Naphtylmethyl-piperidines and pharmaceutical compostions intermediates | |
| ZW12380A1 (en) | Novel 3-vinyl-cephalosporins and their preparation | |
| JPS565207A (en) | Tireeliner and its preparation | |
| GB2051062B (en) | 3-vinyl-cephalosporin derivatives and their preparation | |
| JPS5422497A (en) | Novel polyether compound* preparation thereof and use as pharmaceutical | |
| GB2051794B (en) | Hydroxyamino-eburnane derivatives their preparation and use pharmalceutical compositions containing them and intermediates therefor | |
| GB2010806A (en) | Pyrindines and their preparation formulations and use | |
| NZ193557A (en) | 4-phenylchroman derivatives intermediates and pharmaceutical compositions | |
| DE3064789D1 (en) | New 25-hydroxy-24-oxocholestane derivatives and preparation thereof | |
| DE3071198D1 (en) | Acridinones, their preparation and use; intermediates and their preparation | |
| GB2048250B (en) | 2-amino-6-aryl-4-pyrimidinols and their pharmaceutical uses | |
| NZ192886A (en) | Preparation of 7-acylindolin-2-ones and intermediates therein | |
| DE3060100D1 (en) | Omega-halogeno-acetophenone oxime ethers, preparation thereof and their use as intermediates in the preparation of omega-azolyl-acetophenone oxime ethers | |
| ZW11780A1 (en) | Novel pesticides preparation and use | |
| EP0044954A3 (en) | Anthracyclinglycosides, their preparation and intermediates, and pharmaceutical preparations | |
| GB2009739B (en) | A-40104 antibiotics their preparation use and formulations containing them |